Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
Portfolio Pulse from
Profound Medical has announced the pricing of a US$35 million underwritten public offering of common shares. The base shelf prospectus is accessible, and the final prospectus supplement will be available within two business days on SEDAR+ and EDGAR.
December 06, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Profound Medical is conducting a US$35 million underwritten public offering of common shares, which may impact its stock price due to potential dilution.
The announcement of a public offering typically leads to a short-term decrease in stock price due to dilution concerns. Investors may react negatively as the increase in shares can dilute existing shareholder value.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100